Microbiological status of patients with inflammatory bowel diseases

Objective. To study the microbial composition of biopsies in inflammatory bowel diseases. Materials and Methods. From November 2019 to February 2023, 100 patients of the coloproctology department with inflammatory bowel diseases (IBD) were examined: 65 patients with ulcerative colitis and 35 pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Khalitova Yu.A., Zhestkov A.V., Myakisheva Yu.V.
Format: Article
Language:Russian
Published: Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2025-03-01
Series:Клиническая микробиология и антимикробная химиотерапия
Subjects:
Online Access:https://cmac-journal.ru/publication/2025/1/cmac-2025-t27-n1-p94/cmac-2025-t27-n1-p94.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849715584298647552
author Khalitova Yu.A.
Zhestkov A.V.
Myakisheva Yu.V.
author_facet Khalitova Yu.A.
Zhestkov A.V.
Myakisheva Yu.V.
author_sort Khalitova Yu.A.
collection DOAJ
description Objective. To study the microbial composition of biopsies in inflammatory bowel diseases. Materials and Methods. From November 2019 to February 2023, 100 patients of the coloproctology department with inflammatory bowel diseases (IBD) were examined: 65 patients with ulcerative colitis and 35 patients with Crohn's disease. A metagenomic analysis of biopsies (DNA sequencer Illumina, USA) obtained during endoscopic examination using a standard technique, with a bioiformatic data analysis, was performed. The diversity of microbiomes in the samples was assessed using the Fisher index. The similarity of microbiomes between samples (beta diversity) was estimated using the Bray–Curtis distance. The analysis of the main coordinates (PCoA) was performed to visualize the similarity of microbiomes between samples. The results were considered statistically significant at p < 0.05. Results. Metagenomic analysis made it possible to study the qualitative and quantitative composition of the intestinal microbiota in patients with ulcerative colitis and Crohn's disease. 20 types of microorganisms were identified, including 146 families, 336 genera, 516 species of microorganisms. At the phylum level, two main ones were obtained: Proteobacteria, Firmicutes. Comparing the studied nosological forms with each other, there is an increase in the diversity of bacteria of the phylum Proteobacteria by 1.2 times in ulcerative colitis. The predominant species of this phylum is Escherichia coli. In turn, the relative abundance of E. coli is 1.6 times higher in patients with Crohn's disease (23.9%/14.48%). Taxonomic categories that are absent in this or that type of disease have been identified – departments: Cyanobacteria (0.049%), Acidobacteria (0.010), Planctomycetes (0.009%), SR1 (0.007%), Synergistetes (0.007%), Chloroflexi (0.004%), Lentisphaerae (0.002%), OD1 (Parcubacteria) (0.001%), Spirochaetes (0.001%), Helicobacter genus (5%) were detected only in patients with ulcerative colitis; department Gemmatimonadetes (0.009%) – with Crohn's disease. Conclusions. Identification of intestinal microorganisms associated with the pathogenesis of inflammatory bowel diseases is a critical aspect for a thorough understanding of the various pathogenic factors that are of great importance for the early detection of IBD.
format Article
id doaj-art-5adf71f5a069423c96e8df87ab22ba6a
institution DOAJ
issn 1684-4386
2686-9586
language Russian
publishDate 2025-03-01
publisher Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
record_format Article
series Клиническая микробиология и антимикробная химиотерапия
spelling doaj-art-5adf71f5a069423c96e8df87ab22ba6a2025-08-20T03:13:18ZrusInterregional Association for Clinical Microbiology and Antimicrobial ChemotherapyКлиническая микробиология и антимикробная химиотерапия1684-43862686-95862025-03-012719410010.36488/cmac.2025.1.94-100cmac-2025-t27-n1-p94Microbiological status of patients with inflammatory bowel diseasesKhalitova Yu.A.0Zhestkov A.V.1Myakisheva Yu.V.2Samara State Medical University, Samara, RussiaSamara State Medical University, Samara, RussiaSamara State Medical University, Samara, RussiaObjective. To study the microbial composition of biopsies in inflammatory bowel diseases. Materials and Methods. From November 2019 to February 2023, 100 patients of the coloproctology department with inflammatory bowel diseases (IBD) were examined: 65 patients with ulcerative colitis and 35 patients with Crohn's disease. A metagenomic analysis of biopsies (DNA sequencer Illumina, USA) obtained during endoscopic examination using a standard technique, with a bioiformatic data analysis, was performed. The diversity of microbiomes in the samples was assessed using the Fisher index. The similarity of microbiomes between samples (beta diversity) was estimated using the Bray–Curtis distance. The analysis of the main coordinates (PCoA) was performed to visualize the similarity of microbiomes between samples. The results were considered statistically significant at p < 0.05. Results. Metagenomic analysis made it possible to study the qualitative and quantitative composition of the intestinal microbiota in patients with ulcerative colitis and Crohn's disease. 20 types of microorganisms were identified, including 146 families, 336 genera, 516 species of microorganisms. At the phylum level, two main ones were obtained: Proteobacteria, Firmicutes. Comparing the studied nosological forms with each other, there is an increase in the diversity of bacteria of the phylum Proteobacteria by 1.2 times in ulcerative colitis. The predominant species of this phylum is Escherichia coli. In turn, the relative abundance of E. coli is 1.6 times higher in patients with Crohn's disease (23.9%/14.48%). Taxonomic categories that are absent in this or that type of disease have been identified – departments: Cyanobacteria (0.049%), Acidobacteria (0.010), Planctomycetes (0.009%), SR1 (0.007%), Synergistetes (0.007%), Chloroflexi (0.004%), Lentisphaerae (0.002%), OD1 (Parcubacteria) (0.001%), Spirochaetes (0.001%), Helicobacter genus (5%) were detected only in patients with ulcerative colitis; department Gemmatimonadetes (0.009%) – with Crohn's disease. Conclusions. Identification of intestinal microorganisms associated with the pathogenesis of inflammatory bowel diseases is a critical aspect for a thorough understanding of the various pathogenic factors that are of great importance for the early detection of IBD.https://cmac-journal.ru/publication/2025/1/cmac-2025-t27-n1-p94/cmac-2025-t27-n1-p94.pdfgut microbiotainflammatory bowel diseaseulcerative colitiscrohn diseaseescherichia сoli
spellingShingle Khalitova Yu.A.
Zhestkov A.V.
Myakisheva Yu.V.
Microbiological status of patients with inflammatory bowel diseases
Клиническая микробиология и антимикробная химиотерапия
gut microbiota
inflammatory bowel disease
ulcerative colitis
crohn disease
escherichia сoli
title Microbiological status of patients with inflammatory bowel diseases
title_full Microbiological status of patients with inflammatory bowel diseases
title_fullStr Microbiological status of patients with inflammatory bowel diseases
title_full_unstemmed Microbiological status of patients with inflammatory bowel diseases
title_short Microbiological status of patients with inflammatory bowel diseases
title_sort microbiological status of patients with inflammatory bowel diseases
topic gut microbiota
inflammatory bowel disease
ulcerative colitis
crohn disease
escherichia сoli
url https://cmac-journal.ru/publication/2025/1/cmac-2025-t27-n1-p94/cmac-2025-t27-n1-p94.pdf
work_keys_str_mv AT khalitovayua microbiologicalstatusofpatientswithinflammatoryboweldiseases
AT zhestkovav microbiologicalstatusofpatientswithinflammatoryboweldiseases
AT myakishevayuv microbiologicalstatusofpatientswithinflammatoryboweldiseases